These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4378338)

  • 21. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permeability of normal and cancerous rat bladder to antineoplastic agents.
    Bessman JD; Johnson RK; Goldin A
    Urology; 1975 Aug; 6(2):187-93. PubMed ID: 807008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for bladder cancer.
    Veenema RJ; Romas NA; Fingerhut B
    Urology; 1974 Feb; 3(2):135-9. PubMed ID: 4204755
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravesical and systemic chemotherapy of murine bladder cancer.
    Soloway MS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute nonlymphocytic leukemia following bladder instillations with thiotepa.
    Easton DJ; Poon MA
    Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of postoperative recurrence of bladder cancer: a clinical study].
    Yang D; Li S; Wang H; Li X; Liu S; Han W; Hao J; Zhang H
    Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):464-5. PubMed ID: 11829890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Verification of the effectiveness of Thio-Tepa on tumor tissue in local chemotherapy of bladder papillomatosis].
    Lunglmayr G; Kellner G; Czech K
    Urol Int; 1970; 25(5):493-501. PubMed ID: 5004171
    [No Abstract]   [Full Text] [Related]  

  • 28. [New experience with cytostatics, especially their intra-arterial use in bladder tumors].
    Reuter JH
    Z Urol Nephrol; 1966 Feb; 59(2):125-8. PubMed ID: 4964957
    [No Abstract]   [Full Text] [Related]  

  • 29. [Own experiences with the treatment of papillomatous bladder neoplasms by intracystic administration of Thio-Tepa].
    Dobrzecki W; Kaczmarek A
    Pol Przegl Chir; 1977 Jun; 49(6a):743-8. PubMed ID: 407554
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q; Xu T; Wang XF
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Local chemotherapy of bladder epitheliomas].
    Martinez-Piñeiro JA
    Acta Oncol (Madr); 1970; 9(1):1-27. PubMed ID: 4990619
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer chemotherapy in urology.
    Furnari S; Pavone-Macaluso M; Veroux G; Mattea E
    Urol Int; 1971; 26(4):315-20. PubMed ID: 4331514
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract]   [Full Text] [Related]  

  • 34. [Benign bladder papillomas, prognosis and treatment. Attempt at an anatomo-clinical correlation].
    Tuchschmid D; Luzuy R; Bouzakoura C
    Helv Chir Acta; 1973 Dec; 40(5):795-801. PubMed ID: 4203751
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK; Sen DK
    J Indian Med Assoc; 1980 Nov; 75(9):173-4. PubMed ID: 6785360
    [No Abstract]   [Full Text] [Related]  

  • 37. [Efficacy of chemo-hormonotherapy on the incidence of recurrence in resectable bladder carcinoma].
    Bernardo G; Fantoni S; Colloi D; Cuzzoni Q; Vicini D; Robustelli Della Cuna G
    Minerva Urol; 1979; 31(2):113-8. PubMed ID: 481381
    [No Abstract]   [Full Text] [Related]  

  • 38. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours.
    Kondás J; Szentgyörgyi E
    Ther Hung; 1983; 31(2):55-8. PubMed ID: 6571182
    [No Abstract]   [Full Text] [Related]  

  • 39. [Progress in the internist treatment of bladder tumors].
    Baumgartner G
    Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical chemotherapy in the management of superficial bladder tumors.
    Schulman CC
    Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.